Identification and validation of the anaplastic large cell lymphoma signature

Advances in Experimental Medicine and Biology

Volumn 604, Issue , 2007, Pages 129-136

  Piva, Roberto ^a   Pellegrino, Elisa ^a   Inghirami, Giorgio ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE INHIBITOR; DOXYCYCLINE; ENZYME INHIBITOR; SHORT HAIRPIN RNA; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ANAPLASTIC LYMPHOMA KINASE GENE; CANCER CELL CULTURE; CELL GROWTH; CELL SURVIVAL; CELL TRANSFORMATION; CONFERENCE PAPER; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; LARGE CELL LYMPHOMA; MICROARRAY ANALYSIS; NONHUMAN; NPM GENE; PRIORITY JOURNAL; RNA INTERFERENCE;

EID: 84934435899     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-69116-9_12     Document Type: Conference Paper

References (14)

1. Chiarle, R., Gong, J.Z., Guasparri, I., Pesci, A., Cai, J., Liu, J., Simmons, W.J., Dhall, G., Howes, J., Piva, R. and Inghirami, G. (2003) NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. Blood, 101, 1919-1927.
2. Chiarle, R., Simmons, W.J., Cai, H., Dhall, G., Zamo, A., Raz, R., Karras, J.G., Levy, D.E. and Inghirami, G. (2005) Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. Nat Med, 11, 623-629.
3. Ebert, B.L. and Golub, T.R. (2004) Genomic approaches to hematologic malignancies. Blood, 104, 923-932.
4. Jackson, A.L., Bartz, S.R., Schelter, J., Kobayashi, S.V., Burchard, J., Mao, M., Li, B., Cavet, G. and Linsley, P.S. (2003) Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol, 21, 635-637.
5. Kolfschoten, I.G., van Leeuwen, B., Berns, K., Mullenders, J., Beijersbergen, R.L., Bernards, R., Voorhoeve, P.M. and Agami, R. (2005) A Genetic Screen Identifies PITX1 as a Suppressor of RAS Activity and Tumorigenicity. Cell, 121, 849-858.
6. Kutok, J.L. and Aster, J.C. (2002) Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma. J Clin Oncol, 20, 3691-702.
7. Piva, R., Chiarle, R., Manazza, A.D., Taulli, R., Simmons, W., Ambrogio, C., D'Escamard, V., Pellegrino, E., Ponzetto, C., Palestro, G. and Inghirami, G. (2006) Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas. Blood, 107, 689-697.
8. Pulford, K., Morris, S.W. and Turturro, F. (2004) Anaplastic lymphoma kinase proteins in growth control and cancer. J Cell Physiol, 199, 330-358.
9. Ramji, D.P. and Foka, P. (2002) CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J, 365, 561-575.
10. Shaffer, A.L., Wright, G., Yang, L., Powell, J., Ngo, V., Lamy, L., Lam, L.T., Davis, R.E. and Staudt, L.M. (2006) A library of gene expression signatures to illuminate normal and pathological lymphoid biology. Immunol Rev, 210, 67-85.
11. Smith, R., Owen, L.A., Trem, D.J., Wong, J.S., Whangbo, J.S., Golub, T.R. and Lessnick, S.L. (2006) Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma. Cancer Cell, 9, 405-416.
12. Staudt, L.M. and Dave, S. (2005) The Biology of Human Lymphoid Malignancies Revealed by Gene Expression Profiling. Advances in Immunology. Academic Press, New York, pp. 163-208.
13. Wan, W., Albom, M.S., Lu, L., Quail, M.R., Becknell, N.C., Weinberg, L.R., Reddy, D.R., Holskin, B.P., Angeles, T.S., Underiner, T.L., Meyer, S.L., Hudkins, R.L., Dorsey, B.D., Ator, M.A., Ruggeri, B.A. and Cheng, M. (2006) Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells. Blood, 107, 1617-1623.
14. Westbrook, T.F., Martin, E.S., Schlabach, M.R., Leng, Y., Liang, A.C., Feng, B., Zhao, J.J., Roberts, T.M., Mandel, G., Hannon, G.J., Depinho, R.A., Chin, L. and Elledge, S.J. (2005) A Genetic Screen for Candidate Tumor Suppressors Identifies REST. Cell, 121, 837-848.